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Background: To compare the effect of totally thoracoscopic with conventional, open repair of atrial septal defect.
Methods: Forty atrial septal defect cases were divided into two groups by surgical approach: totally thoracoscopic
approach (group A, n = 20) and conventional open approach (group B, n = 20). In group A, surgical procedures
were performed through three portal incisions in the right lateral chest wall under thoracoscopic vision without the
aid of a computerized robotic surgical system. Notably, all operations were completed by one surgeon who had
just begun using this technique. In group B, the atrial septal defects were repaired in conventional open fashion.
Clinical outcomes and serum levels of tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), interleukin-10 (IL-10),
intercellular adhesion molecule 1 (ICAM-1), and creatine kinase isoenzyme-myocardial band (CK-MB) for the two
groups were evaluated and compared.
Results: All operations were performed successfully without serious complications. Durations of cardiopulmonary
bypass (CPB), CPB setup, aortic cross-clamping, and operative procedure were significantly longer in group A than
in group B (P < 0.05). The recovery times for body temperature and laboratory values of leukocytes were significantly
shorter for group A than for group B (P < 0.05). There were no differences in durations of postoperative assisted
ventilation or intensive care unit and hospital stays, volumes of blood transfused intraoperatively or thoracic drainage,
or medical costs between the two groups. Serum levels of inflammatory factors (TNF-α, IL-6, IL-10, and ICAM-1) and
CK-MB increased significantly in both groups after surgery. However, 6 h and 12 h after surgery, levels of these
inflammatory factors and CK-MB were significantly lower in group A than in group B (P < 0.05).
Conclusions: Thoracoscopic cardiac surgery is technically feasible and safe, with less trauma and quicker
recovery even when done by a surgeon newly introduced to the technique.
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Myocardial damageBackground
Repair of atrial septal defect (ASD) using a totally thora-
coscopic approach is the oldest and most popular appli-
cation of video-assisted thoracoscopic cardiac surgery
[1-3]. Since 2008, we have carried out ASD repair using
a totally thoracoscopic approach with satisfactory clinic
results and without the aid of a computerized robotic
surgical system. However, thoracoscopic cardiac surgery* Correspondence: wuyanhu@njmu.edu.cn
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unless otherwise stated.is still controversial because its minimally invasive na-
ture makes the surgery longer and more difficult, espe-
cially because of the newness of this technique. In the
present study, to evaluate the advantages of this method
when performed by a surgeon newly introduced to this
technique, we compared the outcomes of thoracoscopic
cardiac surgery in 20 consecutive patients with those of
conventional thoracotomy with regard to postoperative
systemic inflammatory response syndrome (SIRS) and
myocardial injury.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Patients and surgeon
Forty patients from our hospital who were diagnosed with
ASD and underwent repair between 2010 and 2012 were
divided into two groups: totally thoracoscopic (group A,
n = 20) and conventional open (group B, n = 20) surgical
approaches. Echocardiograms demonstrated ASD without
other cardiovascular anomalies. Only patients who could
not undergo percutaneous interventional closure because
of defect size or ASD type were included. Various factors
including age, sex, weight, cardiothoracic ratio, cardiac
function as demonstrated by ejection fraction, size of
ASD, and hematocrit were compared. There were no sig-
nificant differences in these parameters between groups
(Table 1). Both methods were considered feasible in the
hospital. Patient consent was not deemed necessary by the
local research and ethics committee (Nanjing Medical
University Institutional Review Board).
Thoracoscopic cardiac surgeries were performed by
one surgeon newly introduced to this technique. The
surgeon’s preoperative preparation included attaining a
large amount of theoretical knowledge of endoscopy and
carrying out a great deal of endoscopic, especially thora-
coscopic, training; mastery of routine and minimally in-
vasive cardiac surgeries and demonstrating the ability to
deal with unexpected situations independently; mastery
of thoracic surgical skill and ability to be trained in total
thoracoscopic lung lobectomy; practice performing the
techniques on pigs; and observation of totally thoraco-
scopic cardiac surgery at other hospitals.
ASD surgical repair
The patients in group A were placed under endotracheal
anesthesia via a double-lumen endotracheal tube and the
femoral artery and vein were cannulated. Left single-lung
ventilation was applied. Oxygen saturation was monitored.
If oxygen saturation fell below 90%, double-lung ventila-
tion was initiated. A 2-cm-long incision was made in the
fifth intercostal space at the right midaxillary line. A trocar
was placed through the incision and the thoracoscope
(Stryker Inc., Kalamazoo, MI, USA) was inserted throughTable 1 Patient baseline characteristics
Group A Group B P
valueVariables (n = 20) (n = 20)
Age (years, mean ± 1SD) 22.13 ± 2.2 27.95 ± 2.3 0.073
Gender (male) 9 (45%) 6 (30%) 0.327
Weight (kg, mean ± 1 SD) 51.13 ± 12.2 51.43 ± 8.8 0.932
Cardiothoracic ratio (%, mean± 1 SD) 52 ± 4.9 53.55 ± 3.6 0.281
EF (%, mean ± 1 SD) 65.53 ± 4.1 68.61 ± 5.2 0.067
Size of ASD (mm, mean ± 1 SD) 29.87 ± 4.73 26.83 ± 7.42 0.182
Hematocrit (%, mean ± 1 SD) 0.39 ± 0.04 0.39 ± 0.03 0.816
ASD, atrial septal defect; EF, ejection fraction; SD, standard deviation.the trocar. Another 2-cm incision was made parasternally
at the third intercostal space for insertion of surgical in-
struments and the inferior vena cava snare. A third 2-cm
incision was made in the second intercostal space at the
right mid-axillary line for insertion of surgical instru-
ments, the superior vena cava snare, a cannula for cold
perfusion, and an aortic clamp (Figure 1). For all intratho-
racic procedures, the surgical field was displayed on a
screen and a computerized robotic surgical system was
not employed. The ASD was closed with direct running
suture and in some cases reinforced with a Dacron patch.
Group B patients underwent with single-lumen endo-
tracheal anesthesia and conventional cardiopulmonary by-
pass (CPB). Patients were positioned supine for access to
the mid-sternal surgical area.
All patients were anesthetized using fentanyl 10-20 μg/kg,
midazolam 0.1-0.15 mg/kg, isoflurane 0.2-1.5%, and/or pro-
pofol 50-100 μg/kg/min. Muscle relaxation was achieved
with rocuronium 0.6-1.0 mg/kg. Heparin was given to
maintain an activated clotting time (ACT) >420 s during
CPB. Bypass management included membrane oxygen-
ation (Affinity NT; Medtronic Inc., Fridley, MN, USA)
and maintenance of mean arterial pressure between 55
and 85 mmHg, temperature between 32 and 35°C, and
blood sugar between 4 and 10 mmol/L. Myocardial pro-
tection was achieved with cold blood crystalloid cardiople-
gia, and terminal warm-blood cardioplegic reperfusion
(a hot-shot) of 250-500 mL was delivered just prior to
the removal of the aortic cross-clamp. After the patient
came off CPB, heparin was reversed with protamine
(approximately 10 mg/1,000 units of heparin). Postop-
eratively, patients were managed in a specialized cardio-
vascular intensive care unit with standardized protocols
for early extubation and blood glucose control (target 5.1
to 8.0 mmol/L).Figure 1 Surgical incisions and portal sites.
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Volumes of blood transfused and thoracic drainage; dura-
tions of CPB setup, CPB, aortic cross-clamping, the opera-
tive procedure, postoperative assisted ventilation, and ICU
and hospital stays; and medical costs were recorded for
both groups.Blood sampling and measurement
Whole venous blood (10 mL) was taken from all patients
preoperatively; immediately after aortic opening; and 2,
6, 12, 24, and 72 h postoperatively. The samples were
centrifuged for 10 min at 3,200 rpm, and the superna-
tants were collected and preserved at -80°C. Levels of
tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6),
intercellular adhesion molecule-1 (ICAM-1), interleukin-
10 (IL-10), and creatine kinase isoenzyme-myocardial
band (CK-MB) were measured by enzyme-linked im-
munosorbent assay (ELISA) using commercially available
ELISA kits (ADL Biotech Inc., Mashteuiatsh, QC, Canada).
All tests on samples and standards were performed in
duplicate per manufacturer instructions.Statistical analysis
Statistical analysis was performed using SPSS for Windows,
Version 13.0 (SPSS Inc., Chicago, IL, USA). All variables
are presented as mean ± standard deviation (SD). Patient
baseline characteristics (except sex, which was compared
using the χ2 test) and operative results were compared
with independent t-tests. One-way analysis of variance
was used to analyze serum levels of inflammatory factors
and CK-MB. A value of P < 0.05 was considered statisti-
cally significant.Table 2 Operative results
G
Variables (mean ± 1 SD) (
CPB time (min) 82
CPB setup time (min) 88.
Aortic cross-clamping time (min) 44
Operation time (h) 4
Recovery time for body temperature (d) 3.
Recovery time for laboratory values of leukocytes (d) 4.
Postoperative respirator-assisting time (h) 13
Units of erythrocytes transfused (U) 3
Amounts of plasma transfused (mL) 753
Thoracic drainage volume (mL) 327
Length of ICU stay (h) 2
Length of hospital stay (days) 10
Medical cost (￥,RMB) 42,63
CPB, cardiopulmonary bypass; ICU, intensive care unit; RMB, Renminbi (Chinese currResults
All operations were performed successfully without serious
complications. Patients in both groups were cured and
were followed for a mean of 24 months (range, 18 to
34 months). All patients could return to work and activities
of daily living and had no long-term complications.
The recovery times for body temperature and laboratory
values of leukocytes were significantly shorter for group A
than for group B (Table 2). There were no differences be-
tween the two groups in durations of postoperative
assisted ventilation or ICU and hospital stays; no differ-
ences in volumes of blood transfused or thoracic drainage,
and no difference in medical costs (Table 2). Durations of
CPB, CPB setup, ascending aortic cross-clamping, and op-
eration were significantly longer in group A than in group
B (Table 2).
Serum levels of inflammatory factors (TNF-α, IL-6,
ICAM-1, IL-10) and CK-MB did not differ significantly
between groups before CPB but significantly increased
after CPB.
TNF-α levels peaked 6 h after aortic opening in both
groups. Values for group B were higher than those for
group A at each time point of CPB and differed signifi-
cantly at 0 h (immediately after aortic opening) and 6,
12, and 24 h after aortic opening (Figure 2).
IL-6 levels peaked 6 h after aortic opening in both
groups. Group B IL-6 values were greater than those for
group A at each time point of CPB and differed signifi-
cantly at 2 and 12 h after aortic opening (Figure 3).
Levels of ICAM-1 peaked 2 h after aortic opening in
both groups. ICAM-1 values were greater in group B than
in group A at each CPB time point and were significantly
different at 2, 6, and 24 h after aortic opening (Figure 4).roup A Group B P
valuen = 20) (n = 20)
.75 ± 18.8 52.45 ± 9.9 <0.001
44 ± 17.13 52.05 ± 21.00 <0.001
.31 ± 12.9 25.31 ± 11.8 0.002
.92 ± 0.7 3.31 ± 0.7 <0.001
13 ± 2.10 5.68 ± 5.20 0.036
31 ± 2.20 7.96 ± 5.00 0.003
.63 ± 7.92 11.15 ± 5.87 0.289
.4 ± 1.9 3.0 ± 1.8 0.477
.1 ± 462.8 685.0 ± 291.1 0.593
.8 ± 219.7 288.5 ± 182.1 0.561
0.9 ± 8.6 21.7 ± 7.7 0.78
.38 ± 1.36 12.30 ± 4.80 0.102
7 ± 4,774.3 39,546 ± 7,974.8 0.181
ency); SD, standard deviation.
Figure 2 Expression of TNF-α in groups A and B. *P < 0.05. Figure 4 Expression of ICAM-1 in groups A and B. *P < 0.05.
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in both groups, with a value significantly higher in group
B than in group A 12 h after aortic opening (Figure 5).
CK-MB level peaked 6 h after aortic opening in group
A and 24 h after aortic opening in group B, with values
greater in group B than in group A at each CPB time
point and significant differences seen 6, 24, and 72 h
after aortic opening (Figure 6).
Discussion
One of the current arguments against totally thoraco-
scopic cardiac surgery is that it does not comply with the
requirements of minimal invasion because the durations
of CPB and ascending aortic cross-clamping associatedFigure 3 Expression of IL-6 in groups A and B. *P < 0.05.with this method are significantly prolonged [4-6]. Open
ASD repair is usually completed by a junior surgeon, and
a senior surgeon often acts as instructor and assistant.
Therefore, operative duration, including CPB and aortic
cross-clamping, were longer in group B. Nevertheless, du-
rations of CPB, CPB setup, aortic cross-clamping, and op-
eration in group B were significantly shorter than in group
A. The corresponding activation of SIRS after CPB in
group A should be more serious and may cause severe im-
pairment of organ function; thus, because of potential
trauma to the patient, the thoracoscopic technique does
not meet the claim of minimal invasion. Especially since
this work had just begun, durations of CPB, CPB setup,
ascending aortic cross-clamping, and operation in groupFigure 5 Expression of IL-10 in groups A and B. *P < 0.05.
Figure 6 Expression of CK-MB in groups A and B. *P < 0.05.
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also longer than in thoracoscopic cardiac surgical proce-
dures completed by a skilled and experienced doctor [3,7].
SIRS occurs after CPB mainly because of the contact
of blood with foreign body surfaces during CPB. This
leads to multi-system and multi-cell activation and pro-
duces a large number of humoral and cellular inflammatory
mediators through a cascade reaction, which eventually
causes tissue and organ damage or even multiple organ
dysfunction syndrome [8-10]. Causes of SIRS also include
surgical injury, anesthesia, changes in body temperature,
organ ischemia/reperfusion injury, machine blood transfu-
sion, hemodilution, and heparin-protamine complexes
[11,12]. It is important to understand the claim of minimal
invasion of totally thoracoscopic cardiac surgery apart
from the size of the incision.
Levels of TNF-α, IL-6, and ICAM-1, which are the main
inflammatory cytokines occurring after CPB and which
play critical roles in the inflammatory cascade, are import-
ant in evaluating SIRS after CPB. They are released first
and are also the most important endogenous mediators in
the inflammatory process after CPB [13-15]. In the
present study, we found that in patients who underwent
totally thoracoscopicASD repair, levels of TNF-α, IL-6,
and ICAM-1 increased early on and were significantly
higher than the increased values induced by CPB, aortic
cross-clamping, and other operation. However, in patients
who underwent thoracoscopicASD repair, elevations in
the levels of TNF-α, IL-6, and ICAM-1 were of short dur-
ation, dropped soon after operation, and were significantly
lower than those in patients who underwent open surgery
at the same period. Our finding suggests that the degree
of SIRS activated by totally thoracoscopicASD repair is
lower than that in conventional surgery if other factors,such as recovery from surgical trauma and postoperative
cardiopulmonary function, are included.
The prognosis of SIRS after CPB also depends on an-
other important factor, the balance between proinflam-
matory factors and anti-inflammatory factors. IL-10 is
an important post-CPB anti-inflammatory factor that
has an endogenous protective effect that counters tissue
and cell destruction caused by inflammatory mediators
[15,16]. However, if the anti-inflammatory response to
SIRS is too strong, it will reduce immune function and
increase the body’s susceptibility to infection, and induce
or aggravate multiple organ failure. The compensatory
anti-inflammatory response syndrome (CARS) is a com-
plex pattern of immunologic responses to severe infec-
tion or injury. Many studies have shown that the timing
and relative magnitude of these responses have a pro-
found impact on patients’ outcomes [17,18]. Our study
suggests that the level of the anti-inflammatory cytokine
IL-10 in totally thoracoscopicASD repair maintains good
homeostasis with levels of inflammatory cytokines,
reaches a peak in the early postoperative period, and
drops quickly. The peak value is also lower than that in
conventional surgery, which indirectly reflects the
smaller systemic inflammatory response of thoracoscopic
cardiac surgery.
CK-MB level in serum increases when there is myocar-
dial injury. It is widely used to determine perioperative
myocardial injury after cardiac surgery and is an import-
ant indicator of the recovery of cardiac function and prog-
nostic risk factors [19,20]. The present study has shown
that the extent of myocardial injury after thoracoscopi-
cASD repair was significantly lower than after conven-
tional surgery, which is a prerequisite for the successful
rehabilitation of patients who undergo cardiac surgery.
The main reasons for SIRS and myocardial injury are
CPB and surgical injury. Compared with conventional
thoracotomy, thoracoscopic cardiac surgery avoids a
large chest incision and sternotomy wound, significantly
reduces tissue damage, and maintains the overall struc-
ture of the thorax. In addition, the blunt trauma of
endoscopic surgery, such as stretching and squeezing
the heart, is greatly decreased. Thus, thoracoscopic car-
diac surgery may prevent SIRS and myocardial injury.
Conclusions
Although it is more difficult and dangerous, after careful
preparation, thoracoscopic cardiac surgery is technically
feasible and creates less trauma and quicker recovery. In
addition, thoracoscopicASD repair, which can be charac-
terized as minimally invasive, results in a reduced sys-
temic inflammatory response after CPB, maintains the
balance of proinflammatory and anti-inflammation factors,
reduces tissue and organ damage, even when performed
by a surgeon new to this technique.
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